ScholarIQanswers from OpenAlex
Erythropoietin and Anemia Treatment
TopicLeading institutions, researchers & key papers
Erythropoietin and Anemia Treatment is a topic indexed in ScholarIQ from OpenAlex.
What is known about Erythropoietin and Anemia Treatment?
ScholarIQrecord summary
This cluster of papers focuses on the role of erythropoietin and its derivatives in the treatment and management of various diseases, including anemia, chronic kidney disease, heart failure, stroke, and cancer. It explores the use of erythropoiesis-stimulating agents, neuroprotective effects, and the impact on hypoxia-inducible factors. Additionally, it addresses the association with iron deficiency and cardiovascular disease.
How many works does Erythropoietin and Anemia Treatment have?
ScholarIQindexed works
Erythropoietin and Anemia Treatment has 318 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Erythropoietin and Anemia Treatment?
ScholarIQopenalex
The OpenAlex for Erythropoietin and Anemia Treatment is on the source record.
What are the most-cited papers on Erythropoietin and Anemia Treatment?
ScholarIQmost cited works
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Francesco Locatelli, Steven Fishbane, Geoffrey A. Block, Iain C. Macdougall
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
Ajay Singh, Lynda A. Szczech, Kezhen L. Tang, Huiman X. Barnhart, Shelly Sapp, Marsha Wolfson, Donal Reddan
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Tilman B. Drüeke, Francesco Locatelli, Naomi Clyne, Kai‐Uwe Eckardt, Iain C. Macdougall, Dimitrios Tsakiris, Hans-Ulrich Burger, Armin Scherhag
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen, Mark E. Cooper, Dick de Zeeuw, Kai-Uwe Eckardt, Jan Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Stefan D. Anker, Josep Comín Colet, Gerasimos Filippatos, Ronnie Willenheimer, Kenneth Dickstein, Helmut Drexler, Thomas F. Lüscher, B. Ya. Bart, Waldemar Banasiak, Joanna Niegowska, Bridget‐Anne Kirwan, Claudio Mori, B. Rothe, Stuart Pocock, Philip A. Poole‐Wilson, Piotr Ponikowski
Where is Erythropoietin and Anemia Treatment research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Erythropoietin and Anemia Treatment is open access?
ScholarIQopen access share
93%OPEN ACCESS